Tag archive for ‘CHA Bio&Diostech’

Pluristem Signs Korean Licensing Deal : Includes $10 million Share Swap

– – The Israeli stem cell company, Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) has signed a strategic partnership and exclusive licensing agreement with South Korea’s Cha Bio&Diostech More...

Wordpress site Developed by Fixing WordPress Problems